Squamous Cell Carcinoma of the Paranasal Sinus
1 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma of the Paranasal Sinus
| Record | Firm | Date |
|---|---|---|
| Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03370276) | H. Lee Moffitt Cancer Center and Research Institute | 2017-12-20 |
Track Squamous Cell Carcinoma of the Paranasal Sinus automatically
Every clearance here is in the API, with alerts when new ones post.